Related Experiment Video
Updated: Apr 21, 2026

17:14
Compact Quantum Dots for Single-molecule Imaging
Published on: October 9, 2012
18.9K
Carbon Quantum Dots as Versatile Nanosystems for Biomedical Innovation: Mechanisms, Applications, and Translational
Jasdev Singh Maan1, Milind Kuruvath Santhosh1, Stevelyn Jia Xin Lee1
1School of Health Sciences, IMU University, Kuala Lumpur, Malaysia.
British Journal of Biomedical Science
|April 20, 2026
Summary
Carbon quantum dots (CQDs) are versatile fluorescent nanomaterials for biomedical uses. This review details their synthesis, applications, and challenges for clinical translation in nanomedicine.
Area of Science:
- Nanomaterials science
- Biomedical engineering
- Chemical synthesis
Background:
- Carbon quantum dots (CQDs) are emerging fluorescent nanomaterials with significant biomedical potential.
- Their tunable photoluminescence, biocompatibility, and surface chemistry enable applications in bioimaging, biosensing, and therapy.
- Advances in synthesis methods offer control over CQDs' optical properties, doping, and surface functionalization.
Purpose of the Study:
- To provide a mechanistic evaluation of recent developments in CQDs for biomedical applications.
- To emphasize how structural attributes influence antimicrobial activity, organelle targeting, and theranostic platforms.
- To identify key design considerations for advancing CQDs toward clinical nanomedicine.
Main Methods:
- Review of synthesis routes (top-down, bottom-up, green) for CQDs.
- Analysis of structure-property relationships influencing biological interactions.
- Evaluation of factors affecting intracellular transport and subcellular localization.
- Assessment of antimicrobial activity and organelle-specific targeting strategies.
Main Results:
- Synthesis conditions and surface states critically govern biological interactions and intracellular fate of CQDs.
- Defined structural attributes correlate with enhanced antimicrobial activity and targeted organelle delivery.
- Integrated imaging-therapy (theranostic) platforms demonstrate CQDs' potential.
- Challenges include synthesis variability, reproducibility issues, and limited toxicity/biodistribution data.
Conclusions:
- Linking synthesis strategies to surface chemistry and biological behavior is crucial for CQD development.
- Standardized characterization and regulatory pathways are needed for clinical translation.
- Careful design considerations are essential for advancing CQDs in next-generation nanomedicine.

